[Retracted] Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

Table 5

Comparison of cardiovascular outcomes between the two groups of patients (n, %).

Index	Control group (n = 35)	Observation group (n = 35)	χ^2 value	P value
Cardiac death	2 (5.71)	0 (0.00)	2.059	0.151
Recurrent myocardial infarction	3 (8.57)	1 (2.86)	1.061	0.303
Severe arrhythmia	8 (22.56)	2 (5.71)	4.200	0.040
Heart failure	6 (17.14)	1 (2.86)	3.968	0.046
Other cardiovascular adverse events	4 (11.43)	3 (8.57)	0.159	0.690